---
figid: PMC10304826__fphar-14-1149659-g009
pmcid: PMC10304826
image_filename: fphar-14-1149659-g009.jpg
figure_link: /pmc/articles/PMC10304826/figure/F9/
number: FIGURE 9
figure_title: ''
caption: hAMSC inhibited the NF-κB signaling pathway. Schematic diagram shows that
  LPS/PQ can stimulate inflammatory responses and lung damage via the NK-κB signaling
  pathway. hAMSCs might inhibit the NK-κB signaling pathway, thereby blocking the
  inflammatory cascade and the progression of ALI.
article_title: Human amnion-derived mesenchymal stem cells attenuate acute lung injury
  in two different acute lung injury mice models.
citation: Yuxuan Wu, et al. Front Pharmacol. 2023;14:1149659.
year: '2023'

doi: 10.3389/fphar.2023.1149659
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.

keywords:
- acute lung injury
- acute respiratory distress syndrome
- lipopolysaccharide
- paraquat
- human amnion-derived mesenchymal stem cells
- NF-κB signaling pathway

---
